Brater D C, Anderson S A, Strowig S
Clin Pharmacol Ther. 1979 Apr;25(4):435-9. doi: 10.1002/cpt1979254435.
Azosemide is a new monosulfamyl diuretic which inhibits solute transport throughout the thick ascending limb of the loop of Henle. This study compared equal amounts of azosemide and furosemide (20, 40, and 80 mg) in normal subjects. No differences occurred at any dose in volume, sodium, or chloride excretion when analyzed as cumulative excretion at 4, 8, or 12 hr. Azosemide 40 mg caused less potassium excretion than 40 mg of furosemide but there was no significant difference in the sodium/potassium excretion ratio. Analysis of the time course of effect showed that compared to furosemide azosemide tended to have a slower onset of effect. Differences in site of action studies between azosemide and furosemide did not manifest as differences in urinary or electrolyte excretion in our normal subjects.
阿佐塞米是一种新型单磺酰胺类利尿剂,可抑制整个髓袢升支粗段的溶质转运。本研究比较了正常受试者中等量的阿佐塞米和呋塞米(20、40和80毫克)。当分析4、8或12小时的累积排泄量时,任何剂量下的尿量、钠或氯排泄均无差异。40毫克阿佐塞米引起的钾排泄比40毫克呋塞米少,但钠/钾排泄比无显著差异。对作用时程的分析表明,与呋塞米相比,阿佐塞米的起效往往较慢。在我们的正常受试者中,阿佐塞米和呋塞米作用部位研究的差异并未表现为尿液或电解质排泄的差异。